EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Sage Open Chronic Disease

ISSN 2755-8428 · SAGE Publications

Latest articles

  1. Combination therapies for hidradenitis suppurativa: Narrative review of current strategies and emerging perspectives

    Andrea Carugno, Stefano Bighetti, Zeno Fratton, Luca Bettolini, Marco Manfredini, Valentina Dini, Giovanni Paolino, Mario Valenti, Marco Campoli, Anna Minuti, Vincenzo Maione, Gianluca Nazzaro, Francesco Maria Lacarrubba, Enzo Errichetti, Santo Raffaele Mercuri, Simone Ribero, Marina Venturini, Marco Romanelli, Giuseppe Micali, Giovanni Pellacani, Caterina Longo, Antonio Costanzo, Angelo Valerio Marzano, Nicola Zerbinati

    Published: 2026-02DOI: 10.1177/27558428261449178

  2. Protocol for EVOLVE-HBV, a study to determine the prevalence and characteristics of chronic hepatitis B virus infection in KwaZulu-Natal, South Africa, to inform interventions for diagnosis, treatment and prevention

    Motswedi Anderson, Tongai G. Maponga, Janine Upton, Gloria Sukali, Lusanda Mazibuko, Kathy Baisley, Theresa Smit, Elizabeth Waddilove, Marion Delphin, Dickman Gareta, Nikiwe Mbatha, Landiwe Ndimande, Njabulo Dayi, Gregory Ording-Jespersen, Njabulo Myeni, Busangani Ngwenya, Nondumiso Mpanza, Katya Govender, Ngcebo Mhlongo, Guy Harling, Alasdair Leslie, Nomathamsanqa Majozi, Dumisani Siwela, Xanthe Hunt, Bongiwe Ndlovu, Lulama Mthethwa, Nokukhanya Msomi, M. Azim Ansari, Resign Gunda, Vasudevan G. Naidoo, Shaun R. G. Temmers, Thumbi Ndung’u, Maryam Shahmanesh, Mark Siedner, Emily B. Wong, Janet Seeley, Thandeka Khoza, Collins Iwuji, Philippa C. Matthews

    Published: 2026-02DOI: 10.1177/27558428261459232

Volumes

2026 · 48

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.